Trial Data Reveals Improved Quality of Life for Ovarian Cancer Patients Taking Rucaparib
stevepb / Pixabay

Trial Data Reveals Improved Quality of Life for Ovarian Cancer Patients Taking Rucaparib

According to a story from BioPortfolio, the biopharmaceutical company Clovis Oncology, Inc. recently released data from a phase 3 clinical trial of patients with recurrent ovarian cancer taking the company's…

Continue Reading Trial Data Reveals Improved Quality of Life for Ovarian Cancer Patients Taking Rucaparib

A Nasal Spray Has Just Become the First New Therapy Approved by the FDA for Cluster Seizures in 20 Years

Cluster Seizures Approximately 1/3 of all epilepsy patients live with uncontrolled seizures. Of these, around 150,000 in the United States alone  experience cluster seizures (otherwise known as acute-repetitive seizures, crescendo…

Continue Reading A Nasal Spray Has Just Become the First New Therapy Approved by the FDA for Cluster Seizures in 20 Years

Each Ankylosing Spondylitis Patient is Unique, This Study Reinforces that to Provide the Best Care, We Must Understand That

A New AS Study A recent study, published in Reumatologia aimed to evaluate how ankylosing spondylitis (AS) patients are coping with their condition on a psychological level. They wanted to investigate…

Continue Reading Each Ankylosing Spondylitis Patient is Unique, This Study Reinforces that to Provide the Best Care, We Must Understand That
GoFundMe for Sara Geurts, Model with Ehlers-Danlos Bedridden After New Diagnosis
https://pixabay.com/en/money-piggy-bank-coins-finance-2180338/

GoFundMe for Sara Geurts, Model with Ehlers-Danlos Bedridden After New Diagnosis

According to a publication from People, Sara Geurts, a 28-year-old model with Ehlers-Danlos syndrome, has been bedridden for several weeks due to complications linked to her condition. Geurts, a Minneapolis…

Continue Reading GoFundMe for Sara Geurts, Model with Ehlers-Danlos Bedridden After New Diagnosis